Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion President & CEO acquired 8,756 shares (option exercise)
  8. 4 Open-market buy President & CEO bought 2,994 shares at an average $7.05 ($21,115)
  9. 4 Open-market sale Chief Business Officer sold 6,000 shares at an average $9.50 ($57,005)
  10. 4 Exercise or conversion Chief Business Officer acquired 8,500 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 37,333 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Exercise or conversion Interim CEO acquired 38,866 shares (option exercise)
  16. 4 Exercise or conversion Interim CEO acquired 3,307 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 14 · 271 filings